Close
ACHEMA MIDDLE EAST 2026

The Role of Partnerships In Managing Clinical Trial Costs

Running a clinical study entails significant costs and necessitates collaboration among sponsors, vendors, CROs, and sites to ensure trial success. At the 13th Annual Clinical...

Insights Into $3.72B Clinical Trial Supplies Market By 2028

The market for clinical trial supplies has shown strong growth recently, expanding from $2.52 billion in 2023 to $2.75 billion in 2024, with a...

New FDA Guidance To Enhance Diversity In Clinical Trials

The FDA has made progress in promoting diversity in clinical trials. Recently, the agency published a draft guidance providing more information on how sponsors...

Great Point Partners Acquires Lyocontract – A German CDMO

On a mission so as to debut the life sciences companies on an international stage, Great Point Partners, the healthcare investment firm, is making...

Transforming In 2024 & Beyond – Prefilled Syringes Market

Prefilled syringes have gone on to make up a decent portion in terms of injectable packaging segment in the past 10 years. As per...

Role of Innovation In The Rise of Prefilled Biologics Space

It is well to be noted that prefilled products, specifically prefilled biologics, happen to be a growing segment in the pharmaceutical sector. Prefilled syringes...

Major Surge Expected In The Injectable Drug Delivery Market

A new report rolled out by MarketsandMarkets has gone on to forecast that the injectable drug delivery market is going to be reaching almost...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...